PROCTER & GAMBLE SHIPPING NYQUIL HOT THERAPY TO TRADE IN MID- JULY
This article was originally published in The Tan Sheet
Executive Summary
PROCTER & GAMBLE SHIPPING NYQUIL HOT THERAPY TO TRADE IN MID- JULY, the firm said. NyQuil Hot Therapy, which is being touted as the only cough/cold product with "real honey lemon taste" and "soothing Vicks vapor," is expected to reach retail shelves by the beginning of August. P&G expects to use a selling line slightly modified from its regular NyQuil tag: "The nighttime, sniffling, sneezing, coughing, aching, stuffy head, fever so you can rest hot liquid medicine." New York-based DMB&B, which promotes the existing NyQuil line, will pick up the extension, the company said. NyQuil Hot Therapy will be available in boxes of six and 10 packets of the honey lemon flavor. The product is indicated to relieve coughs due to minor sore throat, bronchial irritations, runny nose and sneezing due to the common cold, the same indications as P&G's existing NyQuil line. NyQuil Hot Therapy also contains the same active ingredients as the current NyQuil product offerings: acetaminophen (1,000 mg), pseudoephedrine (60 mg), dextromethorphan (30 mg) and doxylamine succinate (12.5 g). NyQuil Hot Therapy will follow in the footsteps of Sandoz' TheraFlu, which virtually created the hot liquid cough/cold remedy category when it was launched in 1989. Since then, TheraFlu has been able to carve out a significant share of the OTC cough/cold market. The Sandoz product generated $ 33 mil. in sales in 1991.